7-OH vs Kratom Leaf: A Side-by-Side Primer

Start with the plant

Kratom is Mitragyna speciosa, a tree in the coffee family native to Southeast Asia. Its leaves contain more than 40 alkaloids. The one present in the largest quantity is mitragynine, which typically makes up 1–2% of dried leaf mass. When people say "kratom leaf" or "kratom powder," they mean the ground plant material carrying that full natural mix.

7-hydroxymitragynine — shortened to 7-OH or 7-hydroxy — is a different, oxidized alkaloid. In raw leaf it is a rounding error: roughly 0.01–0.05% by mass. Products marketed as "7-OH tablets" or "7-OH shots" don't deliver that trace amount. They deliver an isolated or semi-synthetically enriched fraction concentrated far above natural levels, which is exactly why the two categories behave and get regulated differently.

The side-by-side

Percentages above are drawn from published alkaloid profiling of M. speciosa; exact numbers vary by cultivar, region, and drying method. Treat them as ranges, not guarantees.

Why the potency language matters — and its limits

Peer-reviewed pharmacology consistently describes 7-OH as considerably more potent at opioid receptors on a per-milligram basis than mitragynine. That is a laboratory measurement of receptor binding, and it is the honest reason a 30 mg 7-OH tablet is a very different unit than 30 mg of leaf powder. It says nothing about how any person will experience a product, and nothing on this page should be read as a benefit, safety, or dosing recommendation. For a deeper walk-through of the underlying chemistry and how "natural" and enriched 7-OH actually compare, Favor'd Alkz published a breakdown of what the chemistry actually says.

Where mitragynine fits

Because mitragynine is the leaf's headline compound, understanding it is the fastest way to understand why 7-OH products are a separate category. Mitragynine is what a standard kratom COA measures first; 7-OH is the minor alkaloid that concentrated products deliberately push to the front. 7ohBlack keeps a plain-language explainer on mitragynine if you want the parent-alkaloid side of the story before comparing labels.

Regulatory treatment in 2026

This is where the distinction stops being academic. The federal action moving through the process in 2026 is aimed at concentrated 7-OH above a defined threshold — not at ordinary whole-leaf kratom. The DEA's earliest possible scheduling date is August 5, 2026; nothing has taken effect before then. That timing is why so many buyers are suddenly asking whether their specific product is leaf or isolate: the answer changes which rules may apply.

State law is a separate patchwork. As of July 2026:

• Full bans on kratom alkaloids: Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin.
• Shipping ended July 1, 2026: Tennessee and Kansas no longer receive shipments.
• Legal with limits: Mississippi permits sales to adults 21+ statewide except in 11 named counties that prohibit it locally.

Laws move fast in this space, so verify your current state and municipal rules before buying anything — a product legal to ship last month may not be today.

Questions to ask any vendor

Whether you're comparing leaf or 7-OH, the same short checklist separates a transparent seller from a guessing game:

• Is this whole leaf or a concentrated fraction? The label should say which alkaloid it's standardized to.
• How many milligrams of 7-OH per unit? A real 7-OH product states mg per tablet or serving, not just "extra strength."
• Can I see a batch-specific Certificate of Analysis? A current, lot-matched COA from an accredited lab should name the alkaloid concentrations directly.
• Who ran the lab work, and when? Look for an ISO/IEC 17025-accredited lab and a recent test date tied to the batch you're buying.
• Do you ship to my state legally? A compliant vendor blocks banned states and restricted zips rather than shipping and hoping.
• Is the product age-gated to 21+? Responsible sellers verify age before checkout.

The short version

Kratom leaf is the whole plant, led by mitragynine and sold by the gram. 7-OH products isolate a minor alkaloid and sell it by the milligram at concentrations the leaf never reaches on its own. Published research puts 7-OH's per-milligram receptor potency well above mitragynine's, and that gap — not marketing — is why 2026 regulators are drawing a line around concentrated 7-OH specifically. Read the label, read the COA, and read your state's current law before you decide anything.

Frequently asked questions

Is 7-OH the same as kratom?

No. 7-OH (7-hydroxymitragynine) is one trace alkaloid found in the kratom plant. Whole kratom leaf is the ground plant carrying dozens of alkaloids led by mitragynine. Products labeled "7-OH" are concentrated versions of that single minor compound — not ground leaf.

What is the difference between 7-OH and mitragynine?

Mitragynine is the leaf's most abundant alkaloid (~1–2% of mass). 7-OH is a distinct oxidized alkaloid present at roughly 0.01–0.05% in raw leaf. Published pharmacology describes 7-OH as far more potent at opioid receptors per milligram than mitragynine.

Is 7-OH the same as kratom leaf extract?

Not necessarily. A full-spectrum leaf extract concentrates the whole alkaloid profile, still led by mitragynine. A 7-OH product specifically elevates the 7-hydroxymitragynine fraction, so their dominant-alkaloid labels differ even when both are called extracts.

Why do regulators treat 7-OH differently than kratom?

The 2026 DEA action targets concentrated 7-OH above a defined threshold, not ordinary whole-leaf kratom. Regulators distinguish a naturally trace alkaloid sold far above the plant's own levels from the botanical leaf itself.

Is 7-OH legal where I live?

It depends on your state. As of July 2026, Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin ban kratom alkaloids; Tennessee and Kansas ended shipments on July 1, 2026; Mississippi is legal for adults 21+ except in 11 named counties. Federal scheduling could begin no earlier than August 5, 2026. Confirm current local law before buying.